“Individualized Genomic Medicine: Is It Fair?” Co-Director of the Center for Bioethics, Health & Society to speak at Trent Center for Bioethics, Duke University

Center for Bioethics, Health, and Society

Site Content

“Individualized Genomic Medicine: Is It Fair?” Co-Director of the Center for Bioethics, Health & Society to speak at Trent Center for Bioethics, Duke University

Posted on | Back to News & Announcements
Nancy M. P. King, JD, Professor, Dept of Social Sciences & Health Policy, Wake Forest School of Medicine; Co-Director, Center for Bioethics, Health & Society, Wake Forest University to speak as part of the “Humanities in Medicine Lecture Series”.
 
Wednesday, December 5, 2012
12:00-1:00 pm
Duke Hospital Lecture Hall 2003
Lunch provided at NOON
Talk begins at 12:15 PM
 
Much has been made of the thousand-dollar genome and the impact that individualized genomic medicine could have on medicine and health care. But should everybody’s genomes be sequenced? It is critically important for individuals, health care providers, and society to consider the scientific, ethical, and policy promises and pitfalls of genomic sequencing information.
 
Professor King’s scholarship focuses on a range of bioethics issues, including informed consent in health care and research; ethical issues in large-scale genetic research and biobanking, gene transfer research, and regenerative medicine; and connections between science, ethics, design, and policy in biotechnology research. She is co-editor of The Social Medicine Reader (2nd ed., Duke University Press, 2005) and Beyond Regulations: Ethics in Human Subjects Research (UNC Press 1999). She has served on numerous hospital ethics committees, IRBs, DSMBs and on the NIH Recombinant DNA Advisory Committee.
 
Lecture Hall 2003 is one floor directly above the main lobby of Duke Hospital. 
For more information, please contact Trent Center for Bioethics us at (919) 668-9000 or trent-center@duke.edu
 
 

Comments are closed.